Back
LakeShore Biopharma 10K Form
Sell
27
LSB
LakeShore Biopharma
Last Price:
0.76
Seasonality Move:
-14.21%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LSB News And Ratings
See the #1 stock for the next 7 days that we like better than LSB
LSB Financial Statistics
Sales & Book Value
| Annual Sales: | $80.21M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.82 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.39800 |
|---|---|
| Net Income (TTM): | $-26.16M |
| Gross Margin: | $63.74M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
LakeShore Biopharma Earnings Forecast
Key LakeShore Biopharma Financial Ratios
- The Gross Profit Margin over the past 4 years for LSB is 79.48%.
- The Selling, General & Administrative Expenses for LSB have been equal to 74.66% of Gross Profit Margin.
- The Research & Development expenses have been 52.81% of Revenue.
- The Interest Expense is -10.23% of Operating Income.
- The Net Earning history of LSB is -75.59% of Total Revenues.
- Per Share Earnings over the last 4 years have been positive in 0 years.
LakeShore Biopharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | LSB |
| Website: | lakeshorebio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LSB Technical Analysis vs Fundamental Analysis
Sell
27
LakeShore Biopharma (LSB)
is a Sell
Is LakeShore Biopharma a Buy or a Sell?
-
LakeShore Biopharma stock is rated a Sell
The current LakeShore Biopharma [LSB] share price is $0.77. The Score for LSB is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.